Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol for Prevention of Neonatal Respiratory Morbidity in Elective C-Section
NCT04780412Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Sep 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of misoprostol in transient tachypnea of the newborn (TTN), neonatal respiratory distress syndrome (NRDS), sponsored by Ain Shams University. Status: unknown.
02
Drugs
misoprostol
03
Conditions
transient tachypnea of the newborn (TTN)neonatal respiratory distress syndrome (NRDS)
Beyond the preview
Go deeper on NCT04780412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04780412.